المؤلفون: Liu, X, Munro, APS, Wright, A, Feng, S, Janani, L, Aley, PK, Babbage, G, Baker, J, Baxter, D, Bawa, T, Bula, M, Cathie, K, Chatterjee, K, Dodd, K, Enever, Y, Fox, L, Qureshi, E, Goodman, AL, Green, CA, Haughney, J, Hicks, A, Jones, CE, Kanji, N, van der Klaauw, AA, Libri, V, Llewelyn, MJ, Mansfield, R, Maallah, M, McGregor, AC, Minassian, AM, Moore, P, Mughal, M, Mujadidi, YF, Belhadef, HT, Holliday, K, Osanlou, O, Osanlou, R, Owens, DR, Pacurar, M, Palfreeman, A, Pan, D, Rampling, T, Regan, K, Saich, S, Saralaya, D, Sharma, S, Sheridan, R, Stokes, M, Thomson, EC, Todd, S, Twelves, C, Read, RC, Charlton, S, Hallis, B, Ramsay, M, Andrews, N, Lambe, T, Nguyen-Van-Tam, JS, Cornelius, V, Snape, MD, Faust, SN

المصدر: Journal of Infection , 87 (1) pp. 18-26. (2023)

مصطلحات موضوعية: Antibodies, Boosters, COVID-19, Immunisation, Immunogenicity, SARS-CoV-2, T-Cells, Vaccination

وصف الملف: application/pdf

العلاقة: https://discovery.ucl.ac.uk/id/eprint/10171907/1/1-s2.0-S0163445323002475-main.pdfTest; https://discovery.ucl.ac.uk/id/eprint/10171907Test/

الإتاحة: https://discovery.ucl.ac.uk/id/eprint/10171907/1/1-s2.0-S0163445323002475-main.pdfTest
https://discovery.ucl.ac.uk/id/eprint/10171907Test/

المؤلفون: Piggin, M, Smith, E, Mankone, P, Ndegwa, L, Gbesemete, D, Pristerà, P, Bahrami-Hessari, M, Johnson, H, Catchpole, AP, Openshaw, PJM, Chiu, C, Read, RC, Ward, H, Barker, C

العلاقة: pii: S1755-4365(22)00066-4; Piggin, M., Smith, E., Mankone, P., Ndegwa, L., Gbesemete, D., Pristerà, P., Bahrami-Hessari, M., Johnson, H., Catchpole, A. P., Openshaw, P. J. M., Chiu, C., Read, R. C., Ward, H. & Barker, C. (2022). The role of public involvement in the design of the first SARS-CoV-2 human challenge study during an evolving pandemic. Epidemics, 41, pp.100626-. https://doi.org/10.1016/j.epidem.2022.100626Test.; http://hdl.handle.net/11343/335867Test

الإتاحة: https://doi.org/10.1016/j.epidem.2022.100626Test
http://hdl.handle.net/11343/335867Test

المؤلفون: Stuart, ASV, Shaw, RH, Liu, X, Greenland, M, Aley, PK, Andrews, NJ, Cameron, JC, Charlton, S, Clutterbuck, EA, Collins, AM, Darton, T, Dinesh, T, Duncan, CJA, England, A, Faust, SN, Ferreira, DM, Finn, A, Goodman, AL, Green, CA, Hallis, B, Heath, PT, Hill, H, Horsington, BM, Lambe, T, Lazarus, R, Libri, V, Lillie, PJ, Mujadidi, YF, Payne, R, Plested, EL, Provstgaard-Morys, S, Ramasamy, MN, Ramsay, M, Read, RC, Robinson, H, Screaton, GR, Singh, N, Turner, DPJ, Turner, PJ, Vichos, I, White, R, Nguyen-Van-Tam, JS, Snape, MD, Com-COV2 Study Group

المساهمون: Group, Com-COV2 Study

المصدر: Lancet (London, England)
Snape, M D 2022, ' Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2) : a single-blind, randomised, phase 2, non-inferiority trial ', Lancet, vol. 399, no. 10319, pp. 36-49 . https://doi.org/10.1016/S0140-6736Test(21)02718-5

مصطلحات موضوعية: Male, qv_268.5, wa_115, COVID-19/prevention & control, Adjuvants, Vaccine/administration & dosage, qw_806, qw_805, Immunogenicity, Vaccine, Medicine, General & Internal, General & Internal Medicine, parasitic diseases, Humans, Single-Blind Method, 11 Medical and Health Sciences, Aged, COVID-19 Vaccines/administration & dosage, Science & Technology, qv_4, Vaccination/adverse effects, mRNA Vaccines/administration & dosage, Articles, General Medicine, Middle Aged, United Kingdom, Com-COV2 Study Group, 2019-nCoV Vaccine mRNA-1273/administration & dosage, wf_140, qw_160, Female, BNT162 Vaccine/administration & dosage, Life Sciences & Biomedicine, Immunization, Secondary/adverse effects, ChAdOx1 nCoV-19/administration & dosage

وصف الملف: application/pdf; PDF; text

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e72507942631237263460b52b50669b5Test
https://doi.org/10.1016/s0140-6736Test(21)02718-5

المؤلفون: Bates, C, Read, RC, Morice, AH

المصدر: The Lancet ; volume 349, issue 9065, page 1598 ; ISSN 0140-6736

مصطلحات موضوعية: General Medicine

الإتاحة: https://doi.org/10.1016/s0140-6736Test(97)03231-5
https://api.elsevier.com/content/article/PII:S0140673697032315?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S0140673697032315?httpAccept=text/plainTest